Hypothesis: In duodenal enteroendocrine cells (EECs), a subset of X‑linked genes escapes X‑chromosome inactivation (XCI) and contributes to a higher basal expression of nutrient‑sensing and GLP‑1‑regulatory factors in XX individuals. This dosage advantage enhances GLP‑1 secretion in response to luminal nutrients, thereby improving systemic glucose homeostasis and reducing age‑related metabolic decline. Consequently, the female longevity advantage is mediated, at least in part, by X‑linked modulation of the gut‑brain incretin axis.

Mechanistic rationale: Escape from XCI has been documented in metabolic tissues such as adipose and muscle Escape from X-inactivation in metabolic tissues. If similar escape occurs in duodenal EECs, genes encoding glucose transporters (e.g., SLC2A2/GLUT2), sweet‑taste receptors (TAS1R2/TAS1R3), or intracellular calcium‑handling proteins could be expressed from both alleles in XX cells, creating a transcriptional buffer that increases cellular responsiveness to glucose and fatty acids. Elevated intracellular calcium would potentiate exocytosis of GLP‑1‑containing vesicles, augmenting the incretin response after meals. Over a lifespan, this heightened incretin tone would attenuate post‑prandial hyperglycemia, reduce insulin resistance, and lower cumulative oxidative stress—processes linked to accelerated aging in males with a single active X.

Testable predictions:

1. Allele‑specific expression: Single‑cell RNA‑seq of duodenal EECs from young and aged XX and XY mice will reveal biallelic expression (escape) of a defined set of X‑linked genes (e.g., Kdm6a, Ddx3x, Ogt) specifically in XX EECs, with reduced or monoallelic expression in XY cells.
2. GLP‑1 secretion dynamics: Ex vivo duodenal perfusion or primary EEC cultures from XX mice will show higher GLP‑1 release per unit glucose or fatty‑acid stimulus compared with XY counterparts; pharmacological silencing of escapee genes (CRISPRi or siRNA) will abolish this difference.
3. In vivo metabolic impact: XX mice with conditional deletion of a key escapee (e.g., Kdm6a) in enteroendocrine cells (using Villin‑Cre) will exhibit blunted GLP‑1 responses, impaired glucose tolerance, and accelerated age‑related adiposity and fatty‑liver deposition relative to XX controls, bringing their metabolic phenotype closer to that of XY mice.
4. Longevity correlation: Longitudinal tracking of XX mice with EEC‑specific escapee knockdown will demonstrate shortened median lifespan relative to XX controls, whereas XY mice overexpressing the same escapee (via EEC‑targeted transgene) will exhibit extended lifespan and improved metabolic health.

Falsifiability: If allele‑specific expression analysis shows no escape of X‑linked genes in duodenal EECs, or if manipulating escapee expression fails to alter GLP‑1 secretion, glucose tolerance, or lifespan, the hypothesis would be refuted. Conversely, confirmation of the predicted molecular, physiological, and aging phenotypes would support the notion that the X chromosome contributes to female longevity by modulating duodenal nutrient sensing and incretin secretion.